-! :7!-E-)O1, #6#)6)&U7.-!#',!(.-!#J'W6%E) ,
! -7,! (.-! I0! 0Io? u ! .)! 0Io? Tot V! l'! 1a1, )6/$'7M! U7$!U7.!23XA!#.,1.))'&)! ,
!:7!g!, 6&!hC!.)!(8'%)&<')&6/!:.-!(E1#J6%E).-!FC! ,
A88@299@8:4!:4;;<, pp.1284-6249 ,
-!67!'#6#)6)&U7 ,
! #67, 7&,.! (8.M#<&,'7M!#%)$-!#',!(.!<&,7-!:.!('!, pp.7-13 ,
%:5%3-)%+'/$" )%(-1-+%!A{wkC!F;J[t]R!AkBATAkk?V! ! kV! ").&/1A)%3-1, H^C! R&)1.,! ^IV! lE1#J6&:! :./:,&)&%! %.((-! ',.! #6 XV! 0.((! 9&6(6WE! 6L-! 6L! #J'W6%E)6-&-! &/! 1'%,6#J'W.-V! A++07%)70+*$*<-1/$"3%4-%W&!A{{wC!FKPR!>?TBwV! ! ABV! "J6,)1'/! mC! l&7! 5GV! ^67-67&/!lC!"%Jj',)dT06,/&(!XC!I'(6:!^6"%'"/$?! P,61!-`&/!:./:,&)&%!%.((-!)6!'!-&1#(&L&.:!%('--&L&%')&6/!6L!J71'/!'/:!167-.!:./:,&)&%! %.((!-79-.)-V!M03*5%/+"S*03+, p.6 ,
-16! lC! R'`&1! lC! 0'1&/-%J&! X6(').:! )6! 0Io'(#J'u! %6J6,)1'/! mV! 0Ik A)%3-1!0C!5'1'd, &6/!6L!<&,'(!'/:!-.(L!'/)&W./-!9E!-`&/T:.,&<.:!0IA@Bu!:./:,&)&%!%.((-V!U&! IC! 2.(d! KFC! "1&)J! 0^C! ").#)6.! HGC! N.')J! RH6 ^6-)! (E1#J6&:! 67%)&6/! 6L! #,6).%)0V!I&LLW7(').:! 9E! )716,! /.%,6-&-! L'%)6,! '(#J'V! L2%" C*03+5%3-)%+'/$")%(-1-+%!A{{kC!FIJ[k]R!AA@{TAAAoV! ! kAV! 3--.(&/T+')7,.(!0C!2,&d',:!KC!0J.1&/!mCFE#.!X! &/).,L.,6/! :.#./:./%.! 6L! #('-1'%E)6&:! :./:,&)&%! %.((! '%)&<')&6/! '/:! 1&W,')&6/V! L2%" C*03+/$"*."%:5%3-)%+'/$")%(-1-+%!>@@?C!N[F[w]R!AA?wTAAtwV! ! k>V! H.&d&-!2C!27/&/!3C!KJ6-J!N"C!l.j&-!mlC!"&-&,'`!=V!+('-1'%E)6&:!:./:,&)&%!%.((-*!, pp.6-6 ,
%(-1-+%! >@@@C!;G;[?]R!BBoTBkkV! ! ?tV! m(6)13%4-%W&"I-13*`1V!G1-%+'-.-1"A)%3-1,61!'#6#)6)&%!(E1#J6%E).-!)6!-)&17(').!1'%,6#J'W.! %J.16R&)).!QpC!"%J7(d.TQ-)J6LL!m6, E1#J6&:!)&--7.- 3%4-%W&" #))0+*$*<>!>@@tC!P[t]R!kkwTk?tV! ! ?wV! P'/W! P0V! 3/)&1&%,69&'(! ,.'%)&<.! 6MEW.6W./! -#.%&.-*! %6/%.#)-! '/:! %6/),'-1'%E)6&:!:./:,&)&%! %.((!#,.%7,-6,-V!A++0&((!l3V!X117/&)E|-!.',(ETj'%J.,.'7! GC! ").&/1'/! H^V! I./:,&)&%! %.((-! '/:! )J.! %6/)))! 0V! 3! 9('-)! L,61! )J.! #'-)*! %(.','/%.! 6L! '#6#)6)#6#)6) 6L! '#6#)6)71-V!L2%"C*03+&6))! ^HC! 0J.`./&! P2C! F,'1#6/)! +0C! l'd',6j-`&! 4HC! m':(! 3C! R'(`! "P6" %'" /$?! p7%(.6)&:.-!,.(.'-.:!9E!'#6#)6)&%!%.((-!'%)!'-!'!L&/:T1.!-&W/'(!)6!#,616).!#J'W6%E)&%! %&7! X46<&'!)J.!#J'W6%E).!,.%.#)6,!K>3V!L2%"C*03+:6`!=3C!=6.(`.,!IHC!0'1#9.((!+3C!06J./!GGC!+^V!4M#6-7,.!6L! #J6-#J')&:E(-.,&/.! 6/! )J.! -7,L'%.! 6L! '#6#)6)&%! (E1#J6%E).-! )16<'(!9E!1'%IlC!P':6`!=3C!H&%J).,!I3C!m'&(.6L! #J6-#J')&:E(- 6L! )J.! '1&/6#J6-#J6(&#&:! )12%)-&'3>!A{{wC!NIN[k>]R!>tA?{T>tAt?V! ! o?V! P':6`!=3C!:.!0')J.(&/.'7!3C!I'(.`.!IlC!N.IlV!l6--!6L!#J6-#J6(&#&:! '-E11.),E!'/:!-7,L'%.!.M#6-7,.!6L!#J6-#J')&:E(-U7&,.:!L6,!#J'W6%E)6-&-! 6L!'#6#)6)&%!%.((-!9E!1'%,6#J'W7#)'`.!6L!'#6#)6)&%! %.((-V!#))0+-'>!>@@wC!NI&6/! 6L! F&1k!'-!'!#J6-#J')&:E(-&6))! ^HC! l7! ^C! N'/.E! l2C! ^'! ?6W7(L1./)!,.%.#)6,!L6,!'#6#)6)&%!%.((-!7#-),.'1!6L!)J.!4l^QvI6%`Ao@vH'%!16:7(.V! U/'03%!>@@wC!GK[[wAto]R!kB@TkBkV! ! o{V! :.!P,.&)'-!3C!2#&:.,1'(! W,6j)J! L'%)6,! o! [^PKT4o]! 9&/:-! )6! 6M&:&d.:! #J6-#J')&:E(-.,&/.*! &1#(&%')&6/-! L6,! 1'%,6#J'W.!%(.','/%.!6L!'#6#)6)^C!^&j'!mC!"J&/6J','!3C!Xj'1')-7!3C!p'W')'!"V!X:./)&L&%')&6/!6L! '!L'%)6,!)J')!(&/`-!'#6#)6)&%!%.((-!)6!#J'W6%E).-V!U/'03%!>@@>C!GFI[too?]R!Ao>TAowV! ! Ak@! {>V! "%6))!H"C!^%^'J6/!4GC!+6#!"^C!H.'#!43C!0',&%%J&6!HC!06J./!+l66L!'#6#)6)&%!%.((-!&-!1.:&').:!9E!^4HV! U 6L! '#6#)6)&%! %.((-! 9E! #J'W6%E).-V! J%$$2%"U%W"h*3a"A1/(%)>"*."G1-%+1%&!>@A@C!FN[JR!wwTo>V! ! {tV! F6,!44C!K',:/.,!INC!FJ61'-!lC!K66:'((!I^C!2&.(.1.&.,!3C!R&((.))-!H63#6#)6)&%! %.((T:.,&<.:!X03^TB!#,616).-!96)J!1'%,6#J'W.!%J.16')),'%)&6/!)6!'/:!).)J.,&/W!6L! '#6#)6)&%!%.((-V!J%$$"(%/'2"/+("(-..%3%+'-/'-*+!>@A>C!FJ[k]R!twATtw{V! ! {wV! K',:'&!"GC!^%+J&((&#-!m3C!P,'-%J!"0C!G'/--./!RGC!")',.L.(:)!3C!^7,#JET;((,&%J!G46"%'"/$?! 0.((T-7,L'%.!%'(,.)&%7(&/!&/&)&').-!%(.','/%.!6L!<&'9(.!6,!'#6#)6)&%!%.((-!)J,67WJ!),'/-T '%)&<')&6/!6L!lH+!6/!)J.!#J'W6%E).V!J%$$!>@@?C!FN;[>]R!B>ATBBkV! ! {oV! Q9.&:! ^C! F.-/&.,.! 3C! KJ&,&/WJ.((&! PC! P&1&'! K^C! 3#.)6J! lC! +.,L.))&/&! Gl6" %'" /$?! 0'(,.)&%7(&/! .M#6-7,.! :&%)').-! )J.! &117/6W./&%&)E! 6L! %'/%.,! %.((! :.')JV! U/'03%" )%(-1-+%!>@@wC!F;[A]R!?kTtAV! ! {{V! 2,6j/! "C! N.&/&-%J! XC! H6--! 4C! "J'j! mC! 27%`(.E! 0IC! "'<&((! GV! 3#6#)6-&-! :&-'9(.-! 0IBAT 1.:&').:! %.((! :.)'%J1./)! L,61! #J'W6%E).-! #,616)&/W! 9&, pp.6-9, 2006. ,
J&#-)6/!^GC!"'<&((!G6, #6(',&d')&6/!)6!#,616).!.LL&%&./)!9&6L!'#6#)6)&%!%.((-V! C*03+%0a*1>'%"`-*$*<>!>@@wC!HN ,
1!)6! ,
-)! 06, %6W/&d.:!9E!IpKHT AC!'!,.%.#)6,!L6,!:.':!%.((-V!#))0+-'>!>@A>C!;P[k]R!tB?Ttk?V! !, pp.16-23 ,
C! m71.! pC! m&)'! F6, `.! 6M&:&d.:! (6jT:./-&)E!(##J'W6%E)6-&-!6L!'W.:v'#6#)6), pp.3-4 ,
7-J&)'! m6, >@A@C!F[I[k]R!A?A>T A?AwV! !, pp.3-4 ,
1./)! j&)J! (').! '#6#)6)&%!, )&%! %.((-V! M03*5%0+*$*<>!>@@BC!;;[A@]R!>o?BT>otBV! ! ,
7W&E'1'! NC! 36`&! H6, L6,! .LL.%)&<.!'%)&<')&6/!6L!I0-V!C*03+ ,
:'!06, 0+*$*<>! >@@wC! FIH[AA]R! t{k{Tt{?wV! ! ,
V! 4M6-61, E!, vol.6, issue.7116, p.17 ,
).:!J71, pp.6-61 ,
6W6%E)6-&, %10$/3")%(-1-+%!>@@tC!HG&6/! 6L! #.#)&:.T^N0! %61#(.M.-! '%U7&,.:! 9E! F! %.((-V! G1-%+1%! A{{{C! NHP[?kkA]R!{?>T{?kV! ! ! Ak, p.61, 2019. ,
W7%J&!m6, ! )J.! &117/.! -E-).1! 9E! )J.! 17 XX! 1'D6,! J&-)6%61#')&9&(&)E! %61#(.M!16(.%7(.!XT3:V!G1-%+1%!A{{>C!NKP ,
#&:! '7)61').:!)'/:.1!1, M03*5%, pp.6-661 ,
WJ!N6 ,
L&:.! 96/:-!&/!(E-6-61, pp.3-4 ,
))! 3GC! R'))-! 0V! 3 ,
'-61.!-E-)1C, &%&)E!6L!)J.!79&U7&)&/T#,6)11! 0C! H6)J-).&/! lC! 0 6L! )J.! #,6).'-61.! 9(6%`! )J.! :.W,':')&6/! 6L! 16-)! %.^N0!%('--!X!16(.%7(.-V!J%$$!A{{kC!IH ,
,6)'-61, pp.1-1 ,
<'! +mV! 3! 1%:5%3-)%+'/$")%(-1-+%!A{{BC!FIH17,'! m6)6,T1.:&').:! #J'W6%E)6-&-!A)%3-1, &1!&<'-)'<'! +mV! N.')! -J6%`! #,6).&/! w@T'--6%&').:! #.#)&:.-! .(&%&) 5C! ^'W&-),.((&<6(<.1./)! 6L! lQzTA! &/! :./:,&)&%! %.((T1.:&').:! '/)&W./! %,6--T#&6/!6L!&117/.!%61#(.M!:.,&<.:!'/)&W./!)6!0Iou!F!%.((- <&<6V! V3*1%%,)!^lC!"'7).,!2C!2J&W./!L,61!'#6#)6)&%).:!0Fl-V!U/'03%!A{{oC!;JN[ttwA]R!otTo{V! ! ! A?A! >>oV! 3(9.,)! ^lV! I.')JT:.LE&/W! &117/&)E*! :6! '#6#)6)%J.,.! p4C! I',/.((! H2C! 3(9.,)! ^lV! 3#6#)6)&%).:! %&6/! 6L! .M6W./67-! -.(LT'/)&W./-! (.':-! )6! :.(.)&6/! 6L! '7)6,.'%)&<.! 0Io&6/! )6! F! (E1#J6%E).-! )J,67WJ! ^N0TX! '/:! 0IA! &/! )79.0C!I.-67))#6#)6)&%! &/L.%).:! 0Iku! F! (E1#J6%E).-V!V3*1%%G+C!0J'#.,6)!lC!+(71'-!GV!+('-1'%E)6&:!:./:,&)&%! %.+C!31&W6B{wTk@>V! ! >kBV! N67:.!^C!2.,) FJ.! ,6(.! 6L! ./:6#('-1&%!,.)&%7(71T'--6%&').:!'1&/6#.#)&:'-.!A!&/!&117/&)E!)6!&/L.%)&6 4C! l& pC! G67<.! ^C! 269',:! 3C! ^6&)'! 06%>>9! ,.W7(').-! #J'W6-61'(! 1')TABtoV! ! >kwV! l&/!^lC!?J'/!5C!+,6&.))6!3XC!+,')6!"C!R7!lC!N.')J!RH6%)&<.!-7&%&:.!6L!%&)&%! %.((-! 9E! %E)6%J,61.! %! &/D.%)&6/! -J6j-! L7/%)&6/'(! J.).,6W./.&)E!j&)J&/!)J&-!-79-.)V!V3*1%%0C!^&d7`'1&!"C!X-J&W.!XC!X%J&E'/'W&!F6&97).-! )6! %E)6%')&6/! 6L! .M),'%.&6/! 9E! :./:,&)&%! %.((-V! V3*1%%(-+<&" *." '2%" U/'-*+/$" A1/(%)>" *." G1-%+1%&" *." '2%"\+-'% <&<6! :.#(.)&6/!6L!0IAA%u!:./:,&)&%!%.((-!'9,6W').-!#,&1&/W!6L!0Iou!F!%.((-!9E!.M6W./67-! %.((T'--6%&').:!'/)&W./-V!#))0+-'>!>@@>C!FI[>]R!>AAT>>@V! ! >?@V! 2.(d! KFC! "J6,)1'/! mC! 2.<'/! ^GC! N.')J! RHV! 0Io'(#J'u! :./:,&)&%! %.((-! -.(.%)&<.(E! #,.-./)!^N0!%&%).:!/6/%E)6(E)&%!<&,'(!'/:!&/),'%.((7(',!9'%).,&'(!'/)&W./-!&/! <&<6V!C*03+0+*$*<>!>@@?C!FIK[A]R!A{tT>@@V! ! >?AV! +66(.E! GlC! N.')J! RHC! "J6,)1'/! mV! 07))&/W! .:W.*! &/)&W./! &-! #,.-./).:!)6!0Ik!F!%.((-!9E!0IoT!:./:,&)&%!%.((-C!97)!%!)6!0Io!F!%.((-!9E! 0Iou!:./:,&)&%!%.((-V!C*03+, pp.66-76 ,
17!2C!"1.:T"6 %:5%3-)%+'/$" )%(-1-+%!>@@kC!FJJ[k]R!?twT?w{V! ! >twV!, KC! "%J(.%J)! KC! 4-%,&67! pC! I':'W(&6! KC! l.%(.,%! 0V! +('-1'%E)6&:! :./:,&)&%!%.((-!.LL&%&./)(E!%3C!0('E)6/!"C!+'('dd6!3C!^6/).-!^6"%'"/$?! I&,.%)! #,6).'-61.T&/:.#./:./)! %,6--T#,.-./)')&6/! 6L! <&,'(! '/)&W./! 9E! #('-1'%E)6&:! :./:,&)&%!%.((-!6/!1'D6,!J&-)6%61#')&9&(&)E!%61#(.M!%('--!XV!UAT??wV! ! >t?V! N6.LL.(!KC!H%J.!30C!^')J.67:!IC!p'-%&19./&!^C!4-%,&67!pC!l.96&6/!9E!J71'/!#('-1'%E)6&:!:./:,&)&%!%.((-V!#))0+-'>!>@@wC!NI[B]R!koAT k{>V! ! >ttV! "'(&6!^C!+'(16j-`&!^GC!3)d9.,!=V!0#KT1')7,.:!17,&/.! #('-1'%E)6&:! :./:,&)&%! %.((-! ',.! %'#'9(.! 6L! &/! <&<6! #,&1&/W! 6L! L7/%)&6/'(! 0Io! F! %.((! ,.-#6/-.-! )6! ./:6W./67-! 97)! /6)! .M6W./676(-!#J'W6-61'(!#N!)6!,.W7(')3C!+.,.-!3C!0XC!0',16!pC!^6&)'!0C!N'%6J./!p6FJ.!-1'((!KF+'-.! H'%>!%6/),6(-!#J'W6-61'(!'(`'(&/&d')&6#&).! &117/6-7,<.&(('/%.*! &117/6-.(.%)&6 &117/6-79<.lGC!"1E)J!^GV!0'/%.,!&117/6G+C!;,9'!RGC!H69.,)!06%&/61'V!3!+J'-.!XX!),&'(!6L!-'L.)EC!.LL&%'%EC!'/:! &117 ^3C! l.6/W! ^lC! 2'JD')! m"C! K'6! 5C! l7%`.))! R6&%&)E! L,61! )6M&%&)EV! V3*1%%&6/! 6/! 1'D6,! J&-)6%61#')&9&(&)E! %61#(.M! %W&)'!NC!^&d )6! #,6:7%.! XPpTW'11'! 9E! '/! XlTA>T &%J'/&-1! &/! <&<6V! L2%" C*03+7#! PC! 0'19&! 3C! G66-)./! 2C! l661'/! ^RC! :.! =,&.-! XGC! P&W:6,! 0K6J&9&)-!FlHoT1.:&').:!%E)6`&/.! #,6:7%)&6/V!C*03+&96:&.-! )6! )J.! 0T)E#.! (.%)&/-C! lTC!I7(7%!IC!P('1',!3lC!l&!zN6%61&)'/)!'%)&<')&6 7#)'`.! <&'! J71'/! :.%)&/TA! ,.-7()-! &/! #6)./)! '/)&W./T-#.%&L&%! 0Iou! F! %.((! ,.-#6/-.-V!C*03+&W./! )',W.)&/W! )6! '! /6<.(C! I0T&%).:! 0T)E#.! (.%)&/V! L2%" C*03+/$"*."1$-+-1/$"-+4%&'-</'-*+!>@@oC!FFH[t]R!>@{oT>AA@V! ! ! A?w! >{oV! P('%J.,! =C! "#',9.,! PC! F,&##! 0NC! H61'/&! pC! ")6&)d/.,! +V! F',W.)&/W! 6L! .#&:.,1'(! l'/W.,J'/-! %.((-! j&)J! '/)&W./&%! #,6).&/-*! ')).1#)-! )6! J',/.--! )J.&,! #,6#.,)&.-! L6,! &117/6)J.,'#EV!J/+1%3"-))0+*$*<>6"-))0+*'2%3/5>"g"J##!>@@{C!KH[w]R!AABwTAAkwV! ! >{{V! 0'1&/-%J&! XC! =,.1.%! IC! 3J1.)! PC! l'J67:! ^NC! =&((':'/W6-! G3C! ^7,#JE! m^6&96:E!,.-#6/-.-!&/&)&').:!9E!0(.%{3T9.',&/W!:./:,&)&%!%.((-!&/!/6,1'(!'/:!2')LB[TvT ]!1&%.V!I*$%10$, pp.6-6 ,
16)6!NC!I.!0, 0^C!3##'-'1E!+^C!l6)d.!^F6, pp.616-622 ,
7'! ^K6, p.312 ,
%:5%3-)%+'/$")%(-1-+%!A{{tC!FH, %E)6`&/.-V! L2%" C*03+((7dd&! lC! "./6<&(('! lC! ='%%J.((&! 4C! 4WW(.7%.(TF! &117/6)J.,'#E!L67%)&6/!6L!)716,!&117/&)E!'/:! %E)6)6M&%! F! (E1#J6%E).!&)&%! %.((-! ),'/-L.%).:! j&)J! 1.--./W.,! Hp3!'1#(&L&.:!L,61!)716,!%.((-V!J/+1%3"3%&%/312!>@@@C!P[[k]R!A@>oTA@BkV! !, p.616 ,
WJ'1!lG6, p.61 ,
! 36, (-! j&)J! 9,.'-)! %',%&/61'! -)&17(').! )J.! .M#'/-&6/! 6L! ,.W7(')6,E! F! %.((-! jJ&(.!%6/%61&)'/)!.M#6-7&6/! 6L! 1%&L&%C! %E)6)6M&%! FT%.j&)J!)716,!(E-').T#7(-.:!:./:,&)&%!%.((-*!'!%(&/&%'(! ),&'(V!C*03+0+*'2%3/5>!>@@?C!NH, p.61 ,
A)%3-1/+" A&&*1, )1./)! 6L! ':<'/%.:5%3-)%+'/$" )%(-1-+%! >@@@C!FJN, pp.6-61 ,
A)%3-1A)%3-1, C! H'#6-6! KC! 0('E)6/! 3V! X-6(')&60C!K71#.,)!3C!I./&d6)!G+C6%E)&%! #,6%.--V!I*$%10$/3"`-*$*<>"*."'2%"1%$$!>@@wC!FH, pp.679-680 ,
1!)6!-)7:E!06 ,
Mechanisms of MHC class I-restricted antigen processing and cross-presentation, Diana Matheoud 1, pp.145-157, 2005. ,
DOI : 10.1126/science.1085650
Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens, Immunological Reviews, vol.167, issue.1, pp.9-26, 2004. ,
DOI : 10.1172/JCI200317293
How dying cells alert the immune system to danger, Nature Reviews Immunology, vol.171, issue.4, pp.279-289, 2008. ,
DOI : 10.1038/nri2215
Cross-priming in health and disease, Nature Reviews Immunology, vol.68, issue.6, pp.403-414 ,
DOI : 10.1038/nri2780
Taking dendritic cells into medicine, Nature, vol.204, issue.7161, pp.419-426, 2007. ,
DOI : 10.1038/nature06175
Dendritic Cells in Cancer Immunotherapy, Adv Cancer Res, vol.99, pp.363-407, 2008. ,
DOI : 10.1016/S0065-230X(07)99006-5
Vaccination of patients with B???cell lymphoma using autologous antigen???pulsed dendritic cells, Nature Medicine, vol.86, issue.1, pp.52-58, 1996. ,
DOI : 10.1038/nm0196-52
Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo, Journal of Experimental Medicine, vol.183, issue.1, pp.317-322, 1996. ,
DOI : 10.1084/jem.183.1.317
Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer, Clinical Cancer Research, vol.15, issue.3, pp.1086-1095, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-2227
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines, Journal of Experimental Medicine, vol.183, issue.1, pp.87-97, 1996. ,
DOI : 10.1084/jem.183.1.87
Dendritic Cells Loaded With Killed Allogeneic Melanoma Cells can Induce Objective Clinical Responses and MART-1 Specific CD8+ T-cell Immunity, Journal of Immunotherapy, vol.29, issue.5, pp.545-557, 2006. ,
DOI : 10.1097/01.cji.0000211309.90621.8b
Analysis and Characterization of Antitumor T-cell Response After Administration of Dendritic Cells Loaded With Allogeneic Tumor Lysate to Metastatic Melanoma Patients, Journal of Immunotherapy, vol.31, issue.1, pp.101-112, 2008. ,
DOI : 10.1097/CJI.0b013e318159f5ba
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate, Cancer Immunology, Immunotherapy, vol.164, issue.Suppl 2, pp.819-829, 2006. ,
DOI : 10.1007/s00262-005-0078-6
Cross-Priming of Naive Cd8 T Cells against Melanoma Antigens Using Dendritic Cells Loaded with Killed Allogeneic Melanoma Cells, The Journal of Experimental Medicine, vol.163, issue.11, pp.1535-1544, 2000. ,
DOI : 10.1016/S1074-7613(00)80066-7
Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma, Cancer Research, vol.64, issue.14, pp.4973-4979, 2004. ,
DOI : 10.1158/0008-5472.CAN-03-3505
Vaccination of Advanced Hepatocellular Carcinoma Patients with Tumor Lysate-Pulsed Dendritic Cells, Journal of Immunotherapy, vol.28, issue.5, pp.496-504, 2005. ,
DOI : 10.1097/01.cji.0000171291.72039.e2
A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer, Clin Cancer Res, vol.8, pp.1021-1032, 2002. ,
Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis, Cancer Res, vol.60, pp.4446-4452, 2000. ,
CD4 T Cells and Their Role in Antitumor Immune Responses, The Journal of Experimental Medicine, vol.144, issue.5, pp.753-756, 1999. ,
DOI : 10.1084/jem.187.10.1555
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery, Blood, vol.105, issue.6, pp.2465-2472, 2005. ,
DOI : 10.1182/blood-2004-08-3105
Immunotherapy of cancer with dendritic-cell-based vaccines, Cancer Immunology, Immunotherapy, vol.46, issue.2, pp.82-87, 1998. ,
DOI : 10.1007/s002620050465
Dendritic Cells Charged with Apoptotic Tumor Cells Induce Long-Lived Protective CD4+ and CD8+ T Cell Immunity against B16 Melanoma, The Journal of Immunology, vol.171, issue.11, pp.5940-5947, 2003. ,
DOI : 10.4049/jimmunol.171.11.5940
Calreticulin exposure dictates the immunogenicity of cancer cell death, Nature Medicine, vol.279, issue.1, pp.54-61, 2007. ,
DOI : 10.1038/nm1523
URL : https://hal.archives-ouvertes.fr/inserm-00451702
Cancer Gene Therapy: The power of negative thinking, Gene Therapy, vol.4, issue.3, pp.191-193, 2006. ,
DOI : 10.1097/00002371-200501000-00001
Immunogenic and tolerogenic cell death, Nature Reviews Immunology, vol.283, issue.5, pp.353-363, 2009. ,
DOI : 10.1038/nri2545
Dendritic Cells Acquire Antigens from Live Cells for Cross-Presentation to CTL, The Journal of Immunology, vol.166, issue.6, pp.3717-3723, 2001. ,
DOI : 10.4049/jimmunol.166.6.3717
Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes, Proceedings of the National Academy of Sciences, vol.101, issue.16, pp.6092-6097, 2004. ,
DOI : 10.1073/pnas.0304860101
Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo, Blood, vol.115, issue.22, pp.4412-4420, 2010. ,
DOI : 10.1182/blood-2009-11-255935
URL : https://hal.archives-ouvertes.fr/hal-00493469
What is trogocytosis and what is its purpose?, Nature Immunology, vol.4, issue.9, p.815, 2003. ,
DOI : 10.1038/ni0903-815
Cellular protein is the source of cross-priming antigen in vivo, Proceedings of the National Academy of Sciences, vol.101, issue.9, pp.3035-3040, 2004. ,
DOI : 10.1073/pnas.0308345101
Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens., Proceedings of the National Academy of Sciences, vol.89, issue.13, pp.6020-6024, 1992. ,
DOI : 10.1073/pnas.89.13.6020
CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose, Proceedings of the National Academy of Sciences, vol.96, issue.22, pp.12703-12707, 1999. ,
DOI : 10.1073/pnas.96.22.12703
Opinion: Death-defying immunity: do apoptotic cells influence antigen processing and presentation?, Nature Reviews Immunology, vol.104, issue.3, pp.223-231, 2004. ,
DOI : 10.1038/nri11308
URL : https://hal.archives-ouvertes.fr/pasteur-01402360
Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A/MART-1 antigen, International Journal of Cancer, vol.12, issue.3, pp.280-286, 2002. ,
DOI : 10.1002/ijc.10605
Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection, Nature Medicine, vol.162, issue.12, pp.1431-1439, 2007. ,
DOI : 10.1002/eji.200324539
Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells, Cell Death and Differentiation, vol.157, issue.7, pp.991-1005, 2009. ,
DOI : 10.1172/JCI26321
URL : https://hal.archives-ouvertes.fr/pasteur-01402288
Apoptotic Cells Deliver Processed Antigen to Dendritic Cells for Cross-Presentation, PLoS Biology, vol.176, issue.6, p.185, 2005. ,
DOI : 10.1371/journal.pbio.0030185.sd001
URL : https://hal.archives-ouvertes.fr/inserm-00708471
Direct Antigen Presentation and Gap Junction Mediated Cross-Presentation during Apoptosis, The Journal of Immunology, vol.183, issue.2, 2009. ,
DOI : 10.4049/jimmunol.0900861